New Board

Western Resources Reports AGM Results

Retrieved on: 
Monday, May 8, 2023
MNP, Marketing, Milestone (project management), MNP LLP, Audit committee, Grain, New Board, Mining, Executive Committee, Remuneration, Rent assessment committee, Compensated emancipation, Management

The new Board then re-elected Mr. Bill Xue as Chairman of the Company, with Mr. Justin Xing as Chair of the Executive Committee, Mr. Mark Fracchia as Chair of the Nominating and Assessment Committee, Mr.

Key Points: 
  • The new Board then re-elected Mr. Bill Xue as Chairman of the Company, with Mr. Justin Xing as Chair of the Executive Committee, Mr. Mark Fracchia as Chair of the Nominating and Assessment Committee, Mr.
  • Guy Bentinck as Chair of the Audit Committee, Mr. Scott Nagel as Chair of the Compensation Committee and Mr. Andrew Hancharyk as Chair of the Corporate Disclosure Policy Committee.
  • Mr. Nagel brings over 30 years of grain and fertilizer experience to the Company.
  • Western’s Chairman Bill Xue said, “I am very pleased that we now have a very strong board in the Company’s history.

Mogo Announces that Coinsquare has entered into a Business Combination Agreement involving Coinsquare, WonderFi and Coinsmart, creating Canada’s leading public and only fully regulated crypto asset trading platform

Retrieved on: 
Monday, April 3, 2023
Professional Services, Apps, Applications, Technology, Cryptocurrency, Finance, Fintech, Interim, Inc., Effective date, Combination company, FSE, New Board, Business analyst, VSA, IRA, Spiking (fintech), SMRT, Investment, Transaction, WNDR, CFO, TSX, NEO, Combination, Security (finance), Coinsquare, Mogo

“This is a milestone transaction for the crypto industry, creating a unique investment opportunity with the leading crypto exchange in Canada.

Key Points: 
  • “This is a milestone transaction for the crypto industry, creating a unique investment opportunity with the leading crypto exchange in Canada.
  • It is anticipated that the shareholders meetings of each party to the Business Combination Agreement will occur in the second quarter of 2023.
  • Closing is expected to occur thereafter, subject to satisfaction of the closing conditions under the Business Combination Agreement.
  • For more information on the Transaction, please refer to the joint press release issued by the parties to the Business Combination Agreement.

LightInTheBox Announces Appointment of Mr. Jian He as the Chairman of the Board and Other Changes to the Board

Retrieved on: 
Thursday, March 30, 2023
Cloud, New Board, International Management Institute, Bhubaneswar, Commerce Insurance Group, Internet, SMIC, GlobalFoundries, HKSE, Risk management, China Europe International Business School, King's College London, Attention, Peking Union Medical College, Federal Board of Revenue, LITB, Imperial College London, Business administration, Zhejiang University, Fudan University, London, Knowledge, New York Stock Exchange, Transport, LightInTheBox, NYSE, Re London School of Electronics Ltd, Management, Tea, Security (finance), Economics, Philosophy

Mr.

Key Points: 
  • Mr.
  • Mr.
  • He, Ms. Yan and Mr. Yu on their respective new roles at the Company," commented Mr. Yan as the chairman of Board.
  • Mr.

Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing

Retrieved on: 
Wednesday, March 22, 2023
Retina, Glaucoma, DED, New Board, LSP, AON, DME, Coronavirus Scientific Advisory Board, OCS, Diabetic retinopathy, Inflammation, EDT, Pain, Telecanthus, Patient, Ophthalmology, Neuro, Early Bird, Disease, Pharmaceutical industry, Management, Pecten oculi

ZUG, Switzerland, and BOSTON, March 22, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, announces that it will ring the Nasdaq opening bell today to celebrate its public listing on the Nasdaq Stock Market earlier this month.

Key Points: 
  • ZUG, Switzerland, and BOSTON, March 22, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, announces that it will ring the Nasdaq opening bell today to celebrate its public listing on the Nasdaq Stock Market earlier this month.
  • Oculis is advancing multiple late clinical-stage product candidates in key areas of medical need.
  • The Nasdaq opening bell ringing will take place at 9:30am EDT, signifying the start of the day’s trading session.
  • Riad Sherif MD, CEO of Oculis, commented: “We are ringing the opening bell today in celebration of Oculis’ public listing, which would not have been possible without the great support of our investors, our partners and the dedication of our employees.

MacroGenics Provides Corporate Update and 2022 Financial Results

Retrieved on: 
Wednesday, March 15, 2023
Gilead Sciences, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, B7-H3, Cytokine release syndrome, ADC, New Board, ASCO, Clinical trial, Investigational New Drug, DRI, Cancer, Macrogen, Half-life, Telephone, Acute myeloid leukemia, CD123, Docetaxel, T1D, Sale, Syndrome, Webcast, RPF, Patient, PSA, Prostate-specific antigen, Parliamentary Information Technology Committee, FDA, ID, Conference call, Ageing, Gilead, D, Prostate cancer, B7, Research, Food, Therapy, IND, Pharmaceutical industry, Vaccine, Medical imaging, Cryptocurrency, Conference, Incyte

ET

Key Points: 
  • ET
    ROCKVILLE, Md., March 15, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported financial results for the year ended December 31, 2022.
  • MacroGenics initiated the Phase 2 portion of the TAMARACK study of vobra duo in patients with mCRPC in late 2022.
  • MacroGenics believes that removal of the control arm should allow the Company to provide a clinical update in 2024 potentially in support of a subsequent Phase 3 study in mCRPC.
  • The listen-only webcast of the conference call can be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics’ website at http://ir.macrogenics.com/events.cfm.

Nordea Bank Abp: Nomination Board's proposals to Nordea's Annual General Meeting 2023 include two new Board members

Retrieved on: 
Monday, February 13, 2023
Kraft Foods, Remuneration, Annual general meeting, Sampo Group, Robin, Pension, CVS, Nature, Chairperson, AGM, Insurance, ICA Gruppen, Executive, Shareholder, Exercise, New Board, Varma Mutual Pension Insurance Company, Holding company, Pension fund, Management, Investment, Nordea

The Shareholders' Nomination Board of Nordea Bank Abp announces today its proposals to Nordea's Annual General Meeting (AGM) to be held on 23 March 2023.

Key Points: 
  • The Shareholders' Nomination Board of Nordea Bank Abp announces today its proposals to Nordea's Annual General Meeting (AGM) to be held on 23 March 2023.
  • The proposal of the Shareholders' Nomination Board for the Board of Directors to be elected by the 2023 AGM comprises ten members.
  • Chair of the Shareholders' Nomination Board, Niko Pakalén, says: "I'm happy to present the Nomination Board's proposals to the shareholders.
  • The Nomination Board emphasises the importance of Nordea remaining an attractive option for highly competent Board members that fulfil the regulatory requirements.

Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa’s Harmful Proposals

Retrieved on: 
Thursday, February 9, 2023
Telephone, Scan, Sequah Medicine Company, New Board, Mass meeting, ADS, Sarissa, Sale, Professional corporation, FAQ, A Clean Break: A New Strategy for Securing the Realm, Internet, Letter, Management, Amarin Corporation

DUBLIN, Ireland and BRIDGEWATER., N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that it has mailed a letter to shareholders in connection with the General Meeting of Shareholders urging shareholders to vote “AGAINST” all proposals on the WHITE proxy card. The General Meeting of Shareholders is scheduled to be held on February 28, 2023, and shareholders of record as of January 23, 2023, will be entitled to vote at the meeting.

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER., N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that it has mailed a letter to shareholders in connection with the General Meeting of Shareholders urging shareholders to vote “AGAINST” all proposals on the WHITE proxy card.
  • Scan this QR code to learn more about why you should vote AGAINST Sarissa’s harmful proposals on the WHITE proxy card today.
  • Please follow the instructions on the enclosed WHITE proxy card and vote by telephone, internet or mail.
  • Vote on the WHITE proxy card “AGAINST” Sarissa’s harmful proposals today.

National Hemp Association Holds Annual General Meeting

Retrieved on: 
Monday, February 6, 2023
Policy, Research and development, United, Research, In Conversation With, Housing, Food, The Climate Group, Food security, Interview, Cannabis, UN, Legislation, New Board, Congress, UN General Assembly Resolution 60/147, Institute of Scrap Recycling Industries, Fear, FDA, AGM, Organization, THC, FACA, General Counsel of the Army, Committee, CBD, Agriculture, Hemp, NHA

Washington D.C., Feb. 06, 2023 (GLOBE NEWSWIRE) -- The National Hemp Association (NHA) held its annual general meeting to celebrate its achievements and collaborations in the hemp industry over the past year while celebrating its victories over its 10 year operations.

Key Points: 
  • Washington D.C., Feb. 06, 2023 (GLOBE NEWSWIRE) -- The National Hemp Association (NHA) held its annual general meeting to celebrate its achievements and collaborations in the hemp industry over the past year while celebrating its victories over its 10 year operations.
  • The NHA has been at the forefront of advocating for hemp in regenerative agriculture, climate-smart practices, food security, additive manufacturing, and housing stability.
  • Research and Development: The NHA's sister 501(C)(3) organization, Hemp Innovations Foundation (HIF) awarded $15,000 to the Hemp Recycles project.
  • The growing international interest is in direct response to the work that NHA and hemp advocates undertook to return industrial hemp as a legal commodity crop in the United States.

Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership

Retrieved on: 
Thursday, February 2, 2023
Slate, Telephone, Our Boarding House, Scan, MD, Mass meeting, Interview, New Board, Novo Holdings A/S, Chairperson, ADS, Sarissa, Advisory Committee, Cardiology, Professional corporation, Bring Your Board!!, Internet, FDC, Merck, Letter, Management, Security (finance), Internet service provider, Renewable energy, Pharmaceutical industry, Amarin Corporation

DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that it has mailed a letter to shareholders in connection with the General Meeting of Shareholders urging shareholders to vote “AGAINST” all proposals on the WHITE proxy card. The General Meeting of Shareholders is scheduled to be held on February 28, 2023, and shareholders of record as of January 23, 2023, will be entitled to vote at the meeting.

Key Points: 
  • Your Board and management team are actively executing a thoughtful and practical strategic plan designed to create value now.
  • This is a NEW Amarin with a NEW Board, a NEW leadership team and a NEW strategy.
  • The Amarin Board now consists of nine directors – six of whom were appointed in the last year.
  • This is why we recommend that Amarin shareholders vote against adding Sarissa’s slate to the Board.

Muscle Maker Inc. Appoints Two New Members to Its Board of Directors

Retrieved on: 
Thursday, February 2, 2023
Maker, Ecosystem, OON, Partner, New Board, Bayer, Marketing, Wills, Fine chemical

Fort Worth, Texas, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Muscle Maker, Inc. (Nasdaq: GRIL ), (“the Company”), today announced the appointment of Ms. Hannah Oh and Mr. Ray Shankar to its Board of Directors effective March 1, 2023.

Key Points: 
  • Fort Worth, Texas, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Muscle Maker, Inc. (Nasdaq: GRIL ), (“the Company”), today announced the appointment of Ms. Hannah Oh and Mr. Ray Shankar to its Board of Directors effective March 1, 2023.
  • She is an experienced (15+ year) agri-food business leader who has held various senior roles at Bayer.
  • Hannah is also an active member of the global Agri-tech and food tech start-up ecosystem by providing mentorship to entrepreneurs and start up companies.
  • Ray specialises in advising on the establishment of family offices, which includes legacy and estate planning, wills, trusts, family charters/constitutions, tax efficient structures and succession planning.